Double Helices in Dimers of Cyclic Bis-Tetrapyrroles
FULL PAPER
2947.3 (61), 2948.3 (78), 2949.3 (100), 2950.3 (88), 2951.3 (68), 2952.3
(53), 2953.3 (32), 2954.3 (16), 2955.3 (8).
role-H), 6.44 (dd, J=4.2, 2.4 Hz, 4H; pyrrole-H), 5.96 ppm (brs, 4H; pyr-
role-H); UV/Vis (CHCl3): lmax (eꢁ10À5)=412 (0.68), 575 (0.22), 845 nm
(0.17mÀ1 cmÀ1); MS (MALDI-TOF): m/z (%): calcd for C80H44N8Ni2:
1232.24 [M]+; found: 1232.2 (56), 1233.2 (69), 1234.2 (100), 1235.2 (81),
1236.2 (64), 1237.2 (45), 1238.2 (15), 1239.2 (13), 1240.2 (7).
2-tert-Butyl-1,3-bis(3-formylphenylethynyl)benzene (tBuPh-mmm-FOR):
A mixture of 3-bromobenzaldehyde (0.38 g, 2.04 mmol), 1-tert-butyl-3,5-
diethynylbenzene (0.35 g, 1.92 mmol), triethylamine (0.3 mL, 4.1 mmol),
NiII complex of the mono-oxidative coupling derivative of bis-bidipyrrin
([4’a·Ni2]): The fraction following that of 3a was recrystallized from
CHCl3/hexane to afford [4’a·Ni2] (21.5 mg, 10%) as a brown solid. Rf =
0.32 (CH2Cl2); 1H NMR (600 MHz, CDCl3, 208C): d=9.12 (s, 4H; pyr-
role-H), 7.77–7.72 (m, 4H; ArH), 7.68–7.60 (m, 10H; ArH, pyrrole-H),
7.55–7.43 (m, 8H; ArH), 7.40–7.34 (m, 6H; ArH), 6.83–6.70 (m, 6H; pyr-
role-H), 6.65 (d, J=4.2 Hz, 2H; pyrrole-H), 6.61 (d, J=4.2 Hz, 2H; pyr-
role-H), 6.46 (dd, J=4.2, 1.2 Hz, 2H; pyrrole-H), 6.41 (dd, J=3.6,
1.2 Hz, 2H; pyrrole-H), 5.98 ppm (m, 2H; pyrrole-H); UV/Vis (CHCl3):
lmax (eꢁ10À5)=430 (0.61), 560 (0.14), 845 nm (0.11mÀ1 cmÀ1); MS
(MALDI-TOF): m/z (%): calcd for C80H46N8Ni2: 1234.26 [M]+; found:
1234.3 (53), 1234.3 (66), 1235.3 (100), 1236.3 (72), 1237.3 (43).
[PdCl2ACHTUNGTRENNUNG(PPh3)2] (17.5 mg, 0.02 mmol), triphenylphosphine (3.8 mg,
0.01 mmol), and CuI (1 mg, 0.005 mmol) in dry THF (10 mL) was heated
at reflux under nitrogen for 64 h. The reaction mixture was diluted with
CH2Cl2 (50 mL), washed with 0.01m aq. EDTA (80 mL), dried over
Na2SO4, and evaporated to dryness. The residue was purified by silica gel
column chromatography (Wakogel C300, 30% hexane/CH2Cl2) and re-
crystallized from CH2Cl2/hexane to afford tBuPh-mmm-FOR (72.1 mg,
24%) as a dark-red oil. Rf =0.47 (CH2Cl2); 1H NMR (600 MHz, CDCl3,
208C): d=10.03 (s, 2H; CHO), 8.06 (s, 2H; ArH), 7.87 (d, J=7.8 Hz,
2H; ArH), 7.79 (d, J=7.8 Hz, 2H; ArH), 7.57–7.54 (m, 5H; ArH),
1.37 ppm (s, 9H; CH3); MS (FAB): m/z (%): calcd for C28H22O2: 390.16
[M]+; found: 389.7 (100), 390.7 (97).
NiII complex of tBuPh-cBDPR (3b): p-Chloranil (173.6 mg, 7.10 mmol)
was added to a CHCl3 solution (14 mL) of 2b (95.4 mg, 0.07 mmol) and
the mixture was heated at reflux for 50 h. The solvent was evaporated to
dryness and the residue was purified by alumina (CHCl3) and silica gel
column chromatography (Wakogel C300, CHCl3) and recrystallized from
CHCl3/hexane to afford 3b (87.3 mg, 92%) as a brown solid. Rf =0.86
2-tert-Butyl-1,3-bis(3-dipyrrolylmethylphenylethynyl)benzene
(tBuPh-
mmm-DPM): Aldehyde tBuPh-mmm-FOR (120 mg, 0.31 mmol) was dis-
solved in pyrrole (6.0 mL) and degassed by bubbling with nitrogen for
10 min. Trifluoroacetic acid (6.0 mL, 0.035 mmol) was added and the solu-
tion was stirred under N2 at room temperature for 40 min and then
quenched with triethylamine (0.4 mL). The remaining pyrrole was re-
moved by vacuum distillation with gentle heating. The residue was puri-
fied by silica gel column chromatography (Wakogel C300, 1% Et3N/
CH2Cl2) and recrystallized from CH2Cl2/hexane to afford tBuPh-mmm-
1
(CH2Cl2); H NMR (600 MHz, CDCl3, 208C): d=7.72 (s, 4H; ArH), 7.66
(dt, J=7.8, 1.2 Hz, 4H; ArH), 7.57–7.51 (m, 12H; ArH), 7.46 (dd, J=7.8,
7.2 Hz, 4H; ArH), 6.84 (dd, J=4.2, 1.2 Hz, 4H; pyrrole-H), 6.68 (m, 4H;
pyrrole-H), 6.61 (m, 4H; pyrrole-H), 6.44 (dd, J=4.2, 1.2 Hz, 4H; pyr-
role-H), 5.96 (m, 4H; pyrrole-H), 1.38 ppm (s, 18H; CH3); UV/Vis
(CHCl3): lmax (eꢁ10À5)=414 (0.79), 565 (0.27), 846 nm (0.21mÀ1 cmÀ1);
MS (MALDI-TOF): m/z (%): calcd for C88H60N8Ni2: 1344.36: [M]+;
found: 1344.4 (53), 1345.4 (76), 1346.4 (100), 1347.4 (78), 1348.4 (57),
1349.4 (33), 1350.4 (14).
1
DPM (117 mg, 61%) as a light-yellow solid. Rf =0.44 (CH2Cl2); H NMR
(600 MHz, CDCl3, 208C): d=7.98 (brs, 4H; NH), 7.49–7.21 (m, 11H;
ArH), 6.73 (m, 4H; pyrrole-H), 6.17 (m, 4H; pyrrole-H), 5.94 (m, 4H;
pyrrole-H), 5.49 (s, 2H; meso-H), 1.33 ppm (s, 9H; CH3); MS (FAB):
m/z (%): calcd for C44H38N4: 622.31 [M]+; found: 622.4 (100), 623.4 (71).
2-tert-Butyl-1,3-bis(dipyrrolylphenylethynyl)benzene
(tBuPh-mmm-
DPR): DDQ (28.0 mg, 0.12 mmol) was added to a THF solution (15 mL)
of dipyrromethane tBuPh-mmm-DPM (38.4 mg, 0.06 mmol) and the mix-
ture was stirred at 08C for 20 min. The solvent was evaporated to dryness
and the residue was purified by alumina (5% MeOH/CH2Cl2) and silica
gel column chromatography (Wakogel C200; 5% MeOH/CH2Cl2) to
afford tBuPh-mmm-DPR (37.3 mg, 98%) as a brown solid. Rf =0.24
(CH2Cl2); 1H NMR (600 MHz, CDCl3, 208C): d=7.69–7.44 (m, 15H;
ArH, pyrrole-H), 6.61 (m, 4H; pyrrole-H), 6.41 (m, 4H; pyrrole-H),
1.34 ppm (s, 9H; CH3); UV/Vis (CHCl3): lmax (eꢁ10À5)=435 nm
(0.30mÀ1 cmÀ1); MS (FAB): m/z (%): calcd for C44H34N4: 618.28 [M]+;
found: 619.0 (100), 620.0 (65).
NiII complex of tBuPh-mmm-DPR (2b): Pyrene (3.9 mg, 0.02 mmol) and
[NiACHTUNGTRENNUNG(OAc)2·4H2O] (9.6 mg, 0.04 mmol) were added to a CHCl3 solution
(20 mL) of dipyrrin tBuPh-mmm-DPR (23.9 mg, 0.04 mmol) and the mix-
ture was heated at reflux for 46 h. The solvent was evaporated to dryness
and the residue was purified by silica gel column chromatography (Wako-
gel C200; 3% MeOH/CHCl3) and recrystallized from CHCl3/hexane to
Cyclic bis-bidipyrrin cBDPR (4a): A 12m aq. HCl solution (10 mL) was
added to a CHCl3 solution (10 mL) of 3a (69.7 mg, 0.056 mmol) and the
mixture was stirred at room temperature for 1 h. The reaction mixture
was then diluted with aq. NaHCO3 (50 mL), dried over Na2SO4, and
evaporated to dryness. The solution was recrystallized from CHCl3/
hexane to afford 4a (58.4 mg, 92%) as a blue solid. Rf =0.11 (CH2Cl2);
1H NMR (600 MHz, CDCl3, 208C): d=7.72–7.65 (m, 14H; ArH), 7.54–
7.42 (m, 12H; ArH), 7.38 (t, J=7.8 Hz, 4H; ArH), 6.87 (brs, 2H; pyr-
role-H), 6.78 (brs, 2H; pyrrole-H), 6.65 (brs, 2H; pyrrole-H), 6.60 (brs,
2H; pyrrole-H), 6.45 (brs, 2H; pyrrole-H), 6.32 ppm (brs, 2H; pyrrole-
H); UV/Vis (CHCl3): lmax (eꢁ10À5)=410 (0.49), 587 (0.66), 724 nm
(0.34mÀ1 cmÀ1); MS (ESI-TOF): m/z (%): calcd for C80H49N8: 1121.41
[M+H]+; found: 1121.41 (100), 1122.42 (92), 1123.42 (38), 1124.43 (15).
Cyclic bis-bidipyrrin tBuPh-cBDPR (4b):
A 12m aq. HCl solution
(5 mL) was added to CHCl3 solution (5 mL) of 3b (35.5 mg,
a
0.026 mmol) and the mixture was stirred at room temperature for 1 h.
The reaction mixture was then diluted with aq. NaHCO3 (20 mL), dried
over Na2SO4, and evaporated to dryness. The solution was recrystallized
from CHCl3/hexane to afford 4b (26.8 mg, 83%) as a blue solid. Rf =0.12
(CH2Cl2); 1H NMR (600 MHz, CDCl3, 208C): d=7.72–7.65 (m, 8H;
ArH), 7.57–7.55 (m, 6H; ArH), 7.50–7.49 (m, 4H; ArH), 7.46 (t, J=
7.8 Hz, 4H; ArH), 6.87 (brs, 2H; pyrrole-H), 6.78 (brs, 2H; pyrrole-H),
6.66 (brs, 2H; pyrrole-H), 6.60 (brs, 2H; pyrrole-H), 6.45 (brs, 2H; pyr-
role-H), 6.32 (brs, 2H; pyrrole-H), 1.39 ppm (s, 18H; CH3); UV/Vis
(CHCl3): lmax (eꢁ10À5)=411 (0.52), 588 nm (0.66mÀ1 cmÀ1); MS
(MALDI-TOF): m/z (%): calcd for C88H65N8: 1233.53 [M+H]+: 1233.5
(100), 1234.5 (82), 1235.5 (44), 1236.5 (12).
afford 2b (17.1 mg, 66%) as
a white solid. Rf =0.90 (5% MeOH/
CH2Cl2); 1H NMR (600 MHz, CDCl3, 208C): d=9.34 (brs, 8H; pyrrole-
H), 7.62–7.57 (m, 10H; ArH, pyrrole-H), 7.52 (m, 4H; ArH), 7.44–7.43
(m, 4H; ArH), 7.41–7.36 (m, 8H; ArH), 6.77 (brs, 8H; pyrrole-H),
1.37 ppm (s, 18H; CH3); UV/Vis (CHCl3): lmax (eꢁ10À5)=478 nm
(0.92mÀ1 cmÀ1); MS (MALDI-TOF): m/z (%, observed with the use of
2,5-dihydroxybenzoic acid as matrix): calcd for C88H64N8Ni2: 1348.40
[M]+; found: 1348.1 (14), 1349.4 (60), 1350.4 (81), 1351.5 (95), 1352.5
(100), 1353.5 (67), 1354.5 (51), 1355.5 (28).
NiII complex of cyclic bis-bidipyrrin cBDPR (3a): p-Chloranil (403.0 mg,
1.64 mmol) was added to a CHCl3 solution (40 mL) of 2a[12b] (202.7 mg,
0.16 mmol) and the mixture was heated at reflux for 46 h. The solution
was purified by alumina (CHCl3) and silica gel column chromatography
(Wakogel C300, CHCl3) and recrystallized from CHCl3/hexane to afford
3a (171.8 mg, 85%) as a brown solid. Rf =0.85 (CH2Cl2); 1H NMR
(600 MHz, CDCl3, 208C): d=7.75 (s, 2H; ArH), 7.72 (s, 4H; ArH), 7.65
(dt, J=7.2, 1.2 Hz, 4H; ArH), 7.54–7.52 (m, 8H; ArH), 7.46 (dd, J=7.8,
7.2 Hz, 4H; ArH), 7.38 (t, J=7.8 Hz, 2H; ArH), 6.83 (dd, J=4.8, 1.2 Hz,
4H; pyrrole-H), 6.68 (m, 4H; pyrrole-H), 6.62 (d, J=2.4 Hz, 4H; pyr-
CuII complex of cBDPR (3’a): Cu
ACTHNUTRGNEN(UG OAc)2 (24.6 mg, 0.14 mmol) was added
to a CHCl3 solution (5 mL) of bidipyrrin 4a (15.2 mg, 0.014 mmol) and
the mixture was stirred for 25 h at room temperature. The solvent was
evaporated to dryness and the residue was purified by silica gel column
chromatography (Wakogel C300, CHCl3) and recrystallized from CHCl3/
hexane to afford 3’a (8.4 mg, 50%) as an orange solid. Rf =0.81
(CH2Cl2); UV/Vis (CHCl3): lmax (eꢁ10À5)=467 (0.69), 769 nm
(0.49mÀ1 cmÀ1); MS (MALDI-TOF): m/z (%): calcd for C80H44N8Cu2:
Chem. Eur. J. 2010, 16, 11653 – 11661
ꢀ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
11659